Standard BioTools Inc. Common Stock – Chart, Kurs & Nachrichten (NASDAQ:LAB)

Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik

Vierteljährlich Jährlich

Market Capitalization 347.16 M
Employee 389
Founded 1999
CEO N/A
Website www.standardbio.com
Headquarter Delaware, United States
FIGI BBG000S8WQB6
Industry Technology

Gesamtumsatz

Jahresüberschuss

Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)

Gesamtverschuldung

Freier Cashflow

Zahlungsmittel und Zahlungsmitteläquivalente

347.16 M Marktkapitalisierung

Kurs-Gewinn-Verhältnis

-6.4

Preis-Umsatz-Verhältnis

5.73

Standard BioTools Inc

Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits, and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications. Standard BioTools sells products to academic research institutions; translational research and medical centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology and plant and animal research companies; and contract research organizations.